Fisher Funds Management LTD Sells 4,959 Shares of Zoetis Inc. $ZTS

Fisher Funds Management LTD lowered its position in Zoetis Inc. (NYSE:ZTS) by 0.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 569,266 shares of the company’s stock after selling 4,959 shares during the period. Zoetis makes up about 1.9% of Fisher Funds Management LTD’s portfolio, making the stock its 14th largest position. Fisher Funds Management LTD’s holdings in Zoetis were worth $71,830,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in ZTS. Diamond Hill Capital Management Inc. bought a new position in Zoetis during the 3rd quarter worth about $394,010,000. Nordea Investment Management AB increased its holdings in Zoetis by 79.2% during the 4th quarter. Nordea Investment Management AB now owns 4,932,787 shares of the company’s stock worth $622,222,000 after purchasing an additional 2,179,578 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Zoetis by 83.4% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,697,827 shares of the company’s stock worth $394,746,000 after purchasing an additional 1,227,085 shares in the last quarter. Corient Private Wealth LLC increased its holdings in Zoetis by 85.9% during the 2nd quarter. Corient Private Wealth LLC now owns 2,578,593 shares of the company’s stock worth $400,619,000 after purchasing an additional 1,191,840 shares in the last quarter. Finally, First Trust Advisors LP increased its holdings in Zoetis by 342.1% during the 3rd quarter. First Trust Advisors LP now owns 1,485,459 shares of the company’s stock worth $217,352,000 after purchasing an additional 1,149,467 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on ZTS. Citigroup began coverage on Zoetis in a report on Wednesday. They set a “buy” rating and a $145.00 target price for the company. Weiss Ratings cut Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, March 27th. UBS Group set a $136.00 target price on Zoetis in a report on Thursday, January 29th. William Blair reiterated an “outperform” rating on shares of Zoetis in a report on Monday, March 2nd. Finally, Morgan Stanley set a $160.00 target price on Zoetis in a report on Thursday, December 18th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Zoetis presently has an average rating of “Hold” and an average price target of $152.25.

Zoetis Price Performance

Shares of NYSE ZTS opened at $119.15 on Friday. The stock has a market capitalization of $50.12 billion, a price-to-earnings ratio of 19.79, a PEG ratio of 1.84 and a beta of 0.98. The business has a 50-day moving average of $121.83 and a 200-day moving average of $126.65. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. Zoetis Inc. has a fifty-two week low of $113.29 and a fifty-two week high of $172.23.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.Zoetis’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. Zoetis’s dividend payout ratio (DPR) is presently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.